Levstek, T.; Podkrajšek, N.; Rehberger Likozar, A.; Šebeštjen, M.; Trebušak Podkrajšek, K.
The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels. J. Cardiovasc. Dev. Dis. 2022, 9, 127.
https://doi.org/10.3390/jcdd9050127
AMA Style
Levstek T, Podkrajšek N, Rehberger Likozar A, Šebeštjen M, Trebušak Podkrajšek K.
The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels. Journal of Cardiovascular Development and Disease. 2022; 9(5):127.
https://doi.org/10.3390/jcdd9050127
Chicago/Turabian Style
Levstek, Tina, Nik Podkrajšek, Andreja Rehberger Likozar, Miran Šebeštjen, and Katarina Trebušak Podkrajšek.
2022. "The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels" Journal of Cardiovascular Development and Disease 9, no. 5: 127.
https://doi.org/10.3390/jcdd9050127
APA Style
Levstek, T., Podkrajšek, N., Rehberger Likozar, A., Šebeštjen, M., & Trebušak Podkrajšek, K.
(2022). The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels. Journal of Cardiovascular Development and Disease, 9(5), 127.
https://doi.org/10.3390/jcdd9050127
